Walleye Trading LLC Zymeworks Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $87,787 - $140,270	-18,879 Reduced 54.89%	15,514 $95,000
Q2 2022 Aug 08, 2022	SELL	$4.82 - $7.7 $2,607 - $4,165	-541 Reduced 1.55%	34,393 $182,000
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $209,604 - $593,179	34,934 New	34,934 $229,000
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $176,175 - $335,519	-5,906 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $231,042 - $324,770	5,906 New	5,906 $279,000
Q2 2020 Aug 14, 2020	SELL	$33.67 - $40.0 $22,491 - $26,720	-668 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $16,219 - $33,266	668 New	668 $24,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $901M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.